Clinical Trials Directory

Trials / Unknown

UnknownNCT04747678

Adverse Effects of Ivermectin Used in Egypt During COVID-19

Tolerability and Adverse Effects of Using Multiple Doses of Ivermectin in Egypt During Covid 19 Pandemic

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers

Summary

retrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Detailed description

ivermectin was used in Egypt during the pandemic of covid-19 and it was registered in the MOH protocol that has been published in November 2020 the study will document the adverse effects of many patients used ivermectin as aprophylaxis and as a treatment with multiple dose regimens

Conditions

Interventions

TypeNameDescription
DRUGIvermectinretrograde study of common and rare adverse effects of multiple doses of ivermectin used during the coivd 19 pandemic in egypt

Timeline

Start date
2021-02-03
Primary completion
2021-02-28
Completion
2021-03-01
First posted
2021-02-10
Last updated
2021-02-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04747678. Inclusion in this directory is not an endorsement.